Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants

• Main Authors: Muhammad Tahir ul Qamar (Author), Safar M. Alqahtani (Author), Mubarak A. Alamri (Author), Ling-Ling Chen (Author)
• Formato: Livro
• Publicado em: Elsevier, 2020-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The recent pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has raised global health concerns. The viral 3-chymotrypsin-like cysteine protease (3CLpro) enzyme controls coronavirus replication and is essential for its life cycle. 3CLpro is a proven drug discovery target in the cas...